EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

QRxVision: Multimodal QR Encoding and Computer Vision for Domain-Specific Drug Discovery

Mithony Keng iD, Kenneth M Merz iD

Journal of Chemical Information and Modeling · 09.11.2026 · 66 (21) · 13783-13794

DOI: 10.1021/acs.jcim.6c01321 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Chemical Information and Modeling, online erschienen am 28.10.2026. Verfasst von Mithony Keng und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Michigan State University, East Lansing, Michigan48824, United States. Hauptthemen laut MEDLINE: Drug Discovery. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIEHS NIH HHS, NIH.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Computational approaches applied to the drug discovery pipeline are invaluable because of their overall speed or time to solution, sustainability, accessibility combined with ever improving accuracy. Furthermore, the high-throughput virtual screening supports practical sampling of the vast chemical space for target-relevant bioactive compounds that can be experimentally validated further downstream in the drug development process. The current paradigm being practiced in computer-aided drug screening strategies centers around structure-based and ligand-based approaches supported by a range of computational tools including de novo design, molecular dynamics-based approaches, and machine learning (ML). Overall, the latter approach has shown great promise generating models of high computational speed coupled with good accuracy. In this work, we developed QRxVision, a domain-specific multimodal ML model explicitly optimized for kinase target assignment using similarity-based profile matching and retrieval. QRxVision utilizes image vision from a pretrained VGG16 (Visual Geometry Group–16) model for deep spatial feature extraction and cosine similarity calculation. By encoding drug multimodality-associated parameters (MAP) into standardized QR code images, QRxVision can evaluate the similarity between test and reference compounds. Drug targets can then be assigned via transitive profile matching. Validation using kinase inhibitors shows that QRxVision is 71% successful at assigning viable small molecules within the Top-5 predictions (p-value < 0.05). Overall, we believe that with the appropriate algorithmic modifications and domain retargeting, the QRxVision framework can be applied to other target assignment tasks.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug DiscoveryProtein Kinase InhibitorsMachine LearningLigands

Substanzen

Protein Kinase InhibitorsLigands

Autor:innen und Institutionen

  • Department of Chemistry, Michigan State University, East Lansing, Michigan48824, United States.
  • Department of Biochemistry and Molecular Biology, Michigan State University, East Lansing, Michigan48824, United States.

ORCID-Profile: Mithony Keng, Kenneth M Merz

Förderung

  • NIEHS NIH HHS
  • NIH

Zitieren

APA

Keng, M., & Merz, K. M. (2026). QRxVision: Multimodal QR Encoding and Computer Vision for Domain-Specific Drug Discovery. Journal of Chemical Information and Modeling, 66(21), 13783-13794. https://doi.org/10.1021/acs.jcim.6c01321

Vancouver

Keng M, Merz KM. QRxVision: Multimodal QR Encoding and Computer Vision for Domain-Specific Drug Discovery. Journal of Chemical Information and Modeling. 2026;66(21):13783-13794. doi:10.1021/acs.jcim.6c01321

BibTeX
@article{Keng2026,
  author = {Keng, Mithony and Merz, Kenneth M},
  title = {QRxVision: Multimodal QR Encoding and Computer Vision for Domain-Specific Drug Discovery},
  journal = {Journal of Chemical Information and Modeling},
  year = {2026},
  volume = {66},
  number = {21},
  pages = {13783--13794},
  doi = {10.1021/acs.jcim.6c01321}
}
Kostenlos starten →